These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33888772)

  • 1. Effect of linagliptin on glucose metabolism and pancreatic beta cell function in patients with persistent prediabetes after metformin and lifestyle.
    Alvarez-Canales MFL; Salazar-López SS; Farfán-Vázquez D; Martínez-López YE; González-Mena JN; Jiménez-Ceja LM; Vargas-Ortiz K; Evia-Viscarra ML; Montes de Oca-Loyola ML; Folli F; Aguilar-García A; Guardado-Mendoza R
    Sci Rep; 2021 Apr; 11(1):8750. PubMed ID: 33888772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The combination of linagliptin, metformin and lifestyle modification to prevent type 2 diabetes (PRELLIM). A randomized clinical trial.
    Guardado-Mendoza R; Salazar-López SS; Álvarez-Canales M; Farfán-Vázquez D; Martínez-López YE; Jiménez-Ceja LM; Suárez-Pérez EL; Angulo-Romero F; Evia-Viscarra ML; Montes de Oca-Loyola ML; Durán-Pérez EG; Folli F; Aguilar-García A
    Metabolism; 2020 Mar; 104():154054. PubMed ID: 31887309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of prediabetes in clinical practice: targeting insulin resistance and β-cell dysfunction.
    Armato J; DeFronzo RA; Abdul-Ghani M; Ruby R
    Endocr Pract; 2012; 18(3):342-50. PubMed ID: 22068250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Linagliptin Versus Metformin on Glycemic Variability in Patients with Impaired Glucose Tolerance.
    González-Heredia T; Hernández-Corona DM; González-Ortiz M; Martínez-Abundis E
    Diabetes Technol Ther; 2017 Aug; 19(8):471-475. PubMed ID: 28581818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of lifestyle interventions with or without metformin therapy on serum levels of osteoprotegerin and receptor activator of nuclear factor kappa B ligand in patients with prediabetes.
    Arslan MS; Tutal E; Sahin M; Karakose M; Ucan B; Ozturk G; Cakal E; Biyikli Gencturk Z; Ozbek M; Delibasi T
    Endocrine; 2017 Feb; 55(2):410-415. PubMed ID: 27743302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoring Insulin Secretion (RISE): design of studies of β-cell preservation in prediabetes and early type 2 diabetes across the life span.
    RISE Consortium
    Diabetes Care; 2014; 37(3):780-8. PubMed ID: 24194506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A refined-JinQi-JiangTang tablet ameliorates prediabetes by reducing insulin resistance and improving beta cell function in mice.
    Gao LH; Liu Q; Liu SN; Chen ZY; Li CN; Lei L; Sun SJ; Li LY; Liu JL; Shen ZF
    J Ethnopharmacol; 2014; 151(1):675-85. PubMed ID: 24286962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Linagliptin and Voglibose on metabolic profile in patients with Type 2 Diabetes: a randomized, double-blind, placebo-controlled trial.
    Parthan G; Bhansali S; Kurpad AV; Walia R; Bhat K; Bhansali A
    BMC Pharmacol Toxicol; 2018 Jul; 19(1):38. PubMed ID: 29970184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DPP4 INHIBITOR SITAGLIPTIN AS A POTENTIAL TREATMENT OPTION IN METFORMIN-INTOLERANT OBESE WOMEN WITH POLYCYSTIC OVARY SYNDROME: A PILOT RANDOMIZED STUDY.
    Ferjan S; Janez A; Jensterle M
    Endocr Pract; 2018 Jan; 24(1):69-77. PubMed ID: 29144805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects on α- and β-cell function of sequentially adding empagliflozin and linagliptin to therapy in people with type 2 diabetes previously receiving metformin: An exploratory mechanistic study.
    Forst T; Falk A; Andersen G; Fischer A; Weber MM; Voswinkel S; Heise T; Kapitza C; Plum-Mörschel L
    Diabetes Obes Metab; 2017 Apr; 19(4):489-495. PubMed ID: 28009472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test.
    Retnakaran R; Shen S; Hanley AJ; Vuksan V; Hamilton JK; Zinman B
    Obesity (Silver Spring); 2008 Aug; 16(8):1901-7. PubMed ID: 18551118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term therapy with combination dipeptidyl peptidase-4 inhibitor saxagliptin/metformin extended release (XR) is superior to saxagliptin or metformin XR monotherapy in prediabetic women with polycystic ovary syndrome: a single-blind, randomized, pilot study.
    Elkind-Hirsch KE; Paterson MS; Seidemann EL; Gutowski HC
    Fertil Steril; 2017 Jan; 107(1):253-260.e1. PubMed ID: 28228317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exenatide, Metformin, or Both for Prediabetes in PCOS: A Randomized, Open-label, Parallel-group Controlled Study.
    Tao T; Zhang Y; Zhu YC; Fu JR; Wang YY; Cai J; Ma JY; Xu Y; Gao YN; Sun Y; Fan W; Liu W
    J Clin Endocrinol Metab; 2021 Mar; 106(3):e1420-e1432. PubMed ID: 32995892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linagliptin, when compared to placebo, improves CD34+ve endothelial progenitor cells in type 2 diabetes subjects with chronic kidney disease taking metformin and/or insulin: a randomized controlled trial.
    Awal HB; Nandula SR; Domingues CC; Dore FJ; Kundu N; Brichacek B; Fakhri M; Elzarki A; Ahmadi N; Safai S; Fosso M; Amdur RL; Sen S
    Cardiovasc Diabetol; 2020 Jun; 19(1):72. PubMed ID: 32493344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pancreatic beta cell function following liraglutide-augmented weight loss in individuals with prediabetes: analysis of a randomised, placebo-controlled study.
    Kim SH; Liu A; Ariel D; Abbasi F; Lamendola C; Grove K; Tomasso V; Reaven G
    Diabetologia; 2014 Mar; 57(3):455-62. PubMed ID: 24326527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early prevention of diabetes microvascular complications in people with hyperglycaemia in Europe. ePREDICE randomized trial. Study protocol, recruitment and selected baseline data.
    Gabriel R; Boukichou Abdelkader N; Acosta T; Gilis-Januszewska A; Gómez-Huelgas R; Makrilakis K; Kamenov Z; Paulweber B; Satman I; Djordjevic P; Alkandari A; Mitrakou A; Lalic N; Colagiuri S; Lindström J; Egido J; Natali A; Pastor JC; Teuschl Y; Lind M; Silva L; López-Ridaura R; Tuomilehto J;
    PLoS One; 2020; 15(4):e0231196. PubMed ID: 32282852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Withdrawal of medications leads to worsening of OGTT parameters in youth with impaired glucose tolerance or recently-diagnosed type 2 diabetes.
    Hannon TS; Edelstein SL; Arslanian SA; Caprio S; Zeitler PS; Buchanan TA; Ehrmann DA; Mather KJ; Tripputi M; Kahn SE; Nadeau KJ;
    Pediatr Diabetes; 2020 Dec; 21(8):1437-1446. PubMed ID: 32985775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.
    Bianchi C; Miccoli R; Trombetta M; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Cavalot F; Cavallo G; Leonetti F; Bonadonna RC; Del Prato S;
    J Clin Endocrinol Metab; 2013 May; 98(5):2100-5. PubMed ID: 23539736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Steps toward the primary prevention of type II diabetes mellitus. Various epidemiological considerations].
    Flórez H
    Invest Clin; 1997 Mar; 38(1):39-52. PubMed ID: 9235072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful strategy to improve glucose tolerance in Thai obese youth.
    Numbenjapon N; Nakavachara P; Santiprabhob J; Kiattisakthavee P; Wongarn R; Likitmaskul S
    J Med Assoc Thai; 2010 Nov; 93 Suppl 6():S131-8. PubMed ID: 21280526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.